Caricamento...

Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome

Ravulizumab (Ultomiris(®)), a humanized monoclonal antibody that inhibits complement protein C5, is indicated for the treatment of atypical haemolytic uraemic syndrome (aHUS) in several countries, including the USA and those of the EU. Ravulizumab has been re-engineered from eculizumab to extend its...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drugs
Autore principale: Syed, Yahiya Y.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8052220/
https://ncbi.nlm.nih.gov/pubmed/33738756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01481-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !